World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
43
Citations
10248
World Ranking
2957
National Ranking
75

Clare Stirzaker publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Clare Stirzaker sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 76 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Clare Stirzaker D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Clare Stirzaker sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 43 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Clare Stirzaker is affiliated with the Garvan Institute of Medical Research in Australia. Their research spans several key areas within biochemistry, genetics, molecular biology, and medicine, with a significant focus on molecular biology and cancer research.

Their work extensively covers topics related to epigenetics and DNA methylation, genomics and chromatin dynamics, RNA modifications and cancer, cancer genomics and diagnostics, cancer-related gene regulation, prostate cancer treatment and research, and histone deacetylase inhibitors research.

Stirzaker's publication record includes a number of articles in various reputable scientific journals. Selected recent papers include:

  • "Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer," 2020, Nature Communications
  • "Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains," 2020, Nature Communications
  • "DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity," 2021, Cell Reports
  • "Epigenetic Therapies and Biomarkers in Breast Cancer," 2022, Cancers
  • "Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling," 2024, BMC Genomics

They frequently collaborate with other researchers, including Susan J. Clark, Ruth Pidsley, Joanna Achinger-Kawecka, Phuc-Loi Luu, and Qian Du, reflecting multidisciplinary engagement in their research projects.

Stirzaker has published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Clinical Epigenetics, Pathology, Nature Communications, and Cancers. The largest number of their publications appear in bioRxiv, indicating involvement in ongoing and preliminary research dissemination as well as peer-reviewed journals.

Their fields of study are primarily rooted in biochemistry, genetics, and molecular biology with particular attention to the molecular mechanisms underlying cancer and related diseases. Within these broad areas, they focus on advanced topics such as chromatin dynamics, DNA methylation patterns, and the impact of epigenetic regulation on cancer progression and treatment strategies.

Best Publications

  • Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling

    Ruth Pidsley;Ruth Pidsley;Elena Zotenko;Elena Zotenko;Timothy J. Peters;Mitchell G. Lawrence

  • Methyl-CpG-binding domain proteins: readers of the epigenome.

    Qian Du;Phuc-Loi Luu;Clare Stirzaker;Clare Stirzaker;Susan J Clark;Susan J Clark

  • Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA

    Peter M. Warnecke;Clare Stirzaker;John R. Melki;Douglas S. Millar

  • Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band

    Jordi Frigola;Jenny Song;Clare Stirzaker;Rebecca A Hinshelwood

  • DNA methylation: bisulphite modification and analysis.

    Susan J Clark;Aaron Statham;Clare Stirzaker;Peter L Molloy

  • Extensive DNA Methylation Spanning the Rb Promoter in Retinoblastoma Tumors

    Clare Stirzaker;Douglas S. Millar;Cheryl L. Paul;Peter M. Warnecke

  • Identification and resolution of artifacts in bisulfite sequencing

    Peter M Warnecke;Clare Stirzaker;Jenny Song;Christoph Grunau

  • Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations

    Phillippa C. Taberlay;Joanna Achinger-Kawecka;Aaron T.L. Lun;Fabian A. Buske

  • Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

    Christoph Bock;Florian Halbritter;Francisco J. Carmona;Sascha Tierling

  • Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells

    Clare Stirzaker;Jenny Z. Song;Ben Davidson;Susan J. Clark

  • Regional activation of the cancer genome by long-range epigenetic remodeling.

    Saul A. Bert;Mark D. Robinson;Mark D. Robinson;Mark D. Robinson;Dario Strbenac;Aaron L. Statham

  • Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias

    Shalima S. Nair;Marcel W. Coolen;Clare Stirzaker;Jenny Z. Song

  • Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer

    Fátima Valdés-Mora;Jenny Z. Song;Aaron L. Statham;Dario Strbenac

  • The DNA methylation landscape in cancer.

    Ksenia Skvortsova;Ksenia Skvortsova;Clare Stirzaker;Clare Stirzaker;Phillippa Taberlay

  • Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity

    Marcel W. Coolen;Clare Stirzaker;Jenny Z. Song;Aaron L. Statham

  • Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.

    Jenny Z Song;Clare Stirzaker;Janet Harrison;John R Melki

  • Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA

    Aaron L. Statham;Mark D. Robinson;Jenny Z. Song;Marcel W. Coolen

  • Mining cancer methylomes: prospects and challenges

    Clare Stirzaker;Phillippa C. Taberlay;Phillippa C. Taberlay;Aaron L. Statham;Susan J. Clark;Susan J. Clark

  • Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.

    Clare Stirzaker;Elena Zotenko;Jenny Z. Song;Wenjia Qu

  • Repitools: an R package for the analysis of enrichment-based epigenomic data.

    Aaron L. Statham;Dario Strbenac;Marcel W. Coolen;Clare Stirzaker

Frequent Co-Authors

Susan J. Clark
Susan J. Clark Garvan Institute of Medical Research
Mark D. Robinson
Mark D. Robinson University of Zurich
Nicola J. Armstrong
Nicola J. Armstrong Murdoch University
James G. Kench
James G. Kench Royal Prince Alfred Hospital
Terence P. Speed
Terence P. Speed Walter and Eliza Hall Institute of Medical Research
Timothy J. Peters
Timothy J. Peters University of Bristol
Roger R. Reddel
Roger R. Reddel Children's Medical Research Institute
Matt Trau
Matt Trau University of Queensland
Joseph E. Powell
Joseph E. Powell Garvan Institute of Medical Research
Michael Buckley
Michael Buckley University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens doors to many evolving healthcare careers. Many students and professionals may be interested in advancing their qualifications online. If you’re coming from a nursing background, several transition programs can help you make that leap, such as adn to np programs, which are designed for associate degree nurses aiming for advanced practice roles.

For those without prior nursing experience, options like direct entry msn online programs help bridge the gap, making it possible to enter advanced nursing professions from related fields such as biology or other sciences.

Choosing the right university is key to your career growth. If you’re considering a bachelor’s to master’s progression, compare your choices with guides such as capella university vs wgu rn to bsn to evaluate program flexibility, cost, and support.

Affordability is another important consideration. Those with a BSN might be interested in finding the cheapest bsn to msn online programs to minimize education expenses while maximizing career advancement.

Best Scientists Citing Clare Stirzaker

Trending Scientists

Recently Published Articles